Patents by Inventor Richard Hill

Richard Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040160205
    Abstract: A barrier movement operator is having a position sensor in a telescoping barrier control arm is described. A controller, remote from the arm, senses the barrier position to identify limits of barrier travel and to control rate of travel of the barrier between limits. The operator includes both optical and edge sensor obstruction detectors and is responsive to wireless communication for receiving user initiated command signals.
    Type: Application
    Filed: February 18, 2003
    Publication date: August 19, 2004
    Applicant: The Chamberlain Group, Inc.
    Inventors: Eric Robb, Richard Hill, William Gioia, Edward Kukulski
  • Patent number: 6746446
    Abstract: An intravascular electrophysiology (EP) device for the mapping and/or formation of lesions along the isthmus region of a heart that has particular utility in the treatment of atrial flutter. The EP device of the invention has an elongated shaft with a proximal section, a compound-curved or modified pigtail-shaped distal section, and a plurality of at least partially exposed electrodes disposed on an outer surface of the distal section. The electrodes are spaced along a length of the distal section and may be interspersed with at least one temperature sensor located between electrodes. The shape of the distal end of the device enables manipulation of the device by inserting its distal end in the tricuspid valve and retracting the device to bias the section having electrodes along the isthmus to achieve acceptable contact with the region so high frequency (e.g., RF) electrical energy delivered to the electrodes on the distal section of the EP device will form a lesion.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: June 8, 2004
    Assignee: Cardima, Inc.
    Inventors: E. Richard Hill, III, Sung Chun, Reynaldo P. Hilario, Tim Ngeo Huynh, Mahmoud R. Seraj, Robert Obara
  • Publication number: 20040077999
    Abstract: An intravascular catheter system for the treatment of occluded blood vessels that includes tissue displacement or hinged expansion members that are movable from a closed to an open position. An actuating assembly may be provided for moving the tissue expansion members between an open and closed position to exert a substantially lateral distal end force upon the region surrounding an occluded blood vessel. The tissue expansion members may stretch apart, tear or otherwise disrupt a vascular occlusion sufficiently to create a pathway that may support the passage or placement of a guidewire or an interventional vascular device across the occlusion or obstruction. Methods of crossing or displacing a vascular occlusion are further provided that include the positioning of a vascular catheter having at least one hinged spreading member positioned at the distal region of the catheter that is responsive to directed force along the longitudinal axis of the catheter.
    Type: Application
    Filed: August 25, 2003
    Publication date: April 22, 2004
    Inventors: Matthew R. Selmon, Charles F. Milo, Robert L. Wynne, Suresh S. Pai, Kent D. Dell, Charles Gresl, Gerald Hansen, E. Richard Hill
  • Patent number: 6638247
    Abstract: An intravascular catheter system for the treatment of occluded blood vessels that includes tissue displacement or hinged expansion members that are movable from a closed to an open position. An actuating assembly may be provided for moving the tissue expansion members between an open and closed position to exert a substantially lateral distal end force upon the region surrounding an occluded blood vessel. The tissue expansion members may stretch apart, tear or otherwise disrupt a vascular occlusion sufficiently to create a pathway that may support the passage or placement of a guidewire or an interventional vascular device across the occlusion or obstruction. Methods of crossing or displacing a vascular occlusion are further provided that include the positioning of a vascular catheter having at least one hinged spreading member positioned at the distal region of the catheter that is responsive to directed force along the longitudinal axis of the catheter.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: October 28, 2003
    Assignee: LuMend, Inc.
    Inventors: Matthew R. Selmon, Charles F. Milo, Robert L. Wynne, Suresh S. Pai, Kent D. Dell, Charles Gresl, Gerald Hansen, E. Richard Hill, III
  • Patent number: 6533768
    Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: March 18, 2003
    Assignee: The Regents of the University of California
    Inventor: Richard A. Hill
  • Patent number: 6508825
    Abstract: An intravascular catheter system for the treatment of occluded blood vessels that includes tissue displacement or hinged expansion members that are movable from a closed to an open position. An actuating assembly may be, provided for moving the tissue expansion members between an open and closed position to exert a substantially lateral distal end force upon the region surrounding an occluded blood vessel. The tissue expansion members may stretch apart, tear or otherwise disrupt a vascular occlusion sufficiently to create a pathway that may support the passage or placement of a guidewire or an interventional vascular device across the occlusion or obstruction. Methods of crossing or displacing a vascular occlusion are further provided that include the positioning of a vascular catheter having at least one hinged spreading member positioned at the distal region of the catheter that is responsive to directed force along the longitudinal axis of the catheter.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: January 21, 2003
    Assignee: LuMend, Inc.
    Inventors: Matthew R. Selmon, Charles F. Milo, Robert L. Wynne, Suresh S. Pai, Kent D. Dell, Charles Gresl, Gerald Hansen, E. Richard Hill, III
  • Publication number: 20020078363
    Abstract: Disclosed is a device and method for obtaining and utilizing data. A handheld device which is capable of optically scanning or receiving RFID signals from an object, storing the data in an internal memory, and then re-transmitting the data is disclosed. The re-transmitted data may trigger access to an internet web site or other database which provides a user with detailed information relating to the scanned object. The device is also usable as a re-configurable electronic key or may be built into electronic devices to allow reconfiguration by scanning a symbol.
    Type: Application
    Filed: March 23, 2001
    Publication date: June 20, 2002
    Inventors: Richard A. Hill, Richard Penn, Ewald Schoemig, Egil K. Summers, William H. Lace, Louis D. Pheil
  • Patent number: 6402923
    Abstract: An electrochemical reactor is used to electrofill damascene architecture for integrated circuits. A shield is used to screen the applied field during electroplating operations to compensate for potential drop along the radius of a wafer. The shield establishes an inverse potential drop in the electrolytic fluid to overcome the resistance of a thin film seed layer of copper on the wafer.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: June 11, 2002
    Inventors: Steven T. Mayer, Richard Hill, Alain Harrus, Evan Patton, Robert Contolini, Steve Taatjes, Jon Reid
  • Patent number: 6330586
    Abstract: A services provision system provides information services over one or more communications networks and has a software infrastructure divided into domains. Each domain has an intelligent software agent and this community of agents sits in a computing environment represented in each domain by a DPE kernel. The community of agents co-operates to provide service and service management functionality to a user. At least one of the agents is reconfigurable to change the functionality the system makes available. Reconfigurability is based on the use of a plurality of reusable software modules, the agent reconfiguring by selecting a new combination of modules. The software modules themselves incorporate rules, or policies, which determine process steps offered by the modules at run-time. These policies are external to the modules and may be loaded at run-time, allowing dynamic modification to functionality of the system.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: December 11, 2001
    Assignee: British Telecommunications Public Limited Company
    Inventors: Martin John Yates, Ian William Marshall, Julian Richard Hill, Patrick Brian Farley, Mark Bagley
  • Publication number: 20010018596
    Abstract: An intravascular catheter system for the treatment of occluded blood vessels that includes tissue displacement or hinged expansion members that are movable from a closed to an open position. An actuating assembly may be provided for moving the tissue expansion members between an open and closed position to exert a substantially lateral distal end force upon the region surrounding an occluded blood vessel. The tissue expansion members may stretch apart, tear or otherwise disrupt a vascular occlusion sufficiently to create a pathway that may support the passage or placement of a guidewire or an interventional vascular device across the occlusion or obstruction. Methods of crossing or displacing a vascular occlusion are further provided that include the positioning of a vascular catheter having at least one hinged spreading member positioned at the distal region of the catheter that is responsive to directed force along the longitudinal axis of the catheter.
    Type: Application
    Filed: April 13, 2001
    Publication date: August 30, 2001
    Inventors: Matthew R. Selmon, Charles F. Milo, Robert L. Wynne, Suresh S. Pai, Kent D. Dell, Charles Gresl, Gerald Hansen, E. Richard Hill
  • Patent number: 6228370
    Abstract: Pharmaceutical compositions comprising known verotoxins, particularly, verotoxin 1, have been found to be useful in the treatment of mammalian neoplasia, particularly, ovarian cancer and skin cancer. Surprisingly, although verotoxin 1 has previously been shown to have anti-neoplastic activity in vitro, non-lethal doses of verotoxin 1 have been shown to be therapeutically anti-neoplastic in vivo.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: May 8, 2001
    Inventors: Clifford A. Lingwood, Hannah Farkas-Himsley, Richard Hill
  • Patent number: 6196966
    Abstract: A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is beneficial during either retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce “white-out” on the imaging monitor.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: March 6, 2001
    Assignee: Conceptus, Inc.
    Inventors: John Kerin, Charles Milo, Julian N. Nikolchev, James Doty, Dai T. Ton, Richard Hill, Marc Schraner, Tom Kramer
  • Patent number: 6106742
    Abstract: This invention pertains to novel higher solids conductive coating compositions which can be applied by spray and other atomization methods. More particularly, it pertains to novel higher solids conductive coating compositions capable of application by electrostatic atomization methods. While there are many applications in which conductive coatings are useful, the invention is particularly useful for the manufacture of adhesion promoting primer compositions which have higher solids and can be applied by electrostatic atomization methods. The key components of the present invention are:(i) a conductive pigment,(ii) a non-conductive polymeric binder, and(iii) a solvent selected for its ability:(a) to form a stable non-conductive dispersion of a conductive pigment when subjected to an electrostatic potential of 20000+ volts,(b) to provide for a higher solids liquid coatings composition thereby reducing the volatile organic emissions (VOC) during application.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: August 22, 2000
    Assignee: Union Carbide Chemicals & Plastics Technology Corporation
    Inventors: John Nicholas Argyropoulos, Richard Hill Bailey, Kenneth Look Hoy, Gerald Robert Gilliam, Kevin Joseph Riggs
  • Patent number: 6095147
    Abstract: Photodynamic therapy is a new adjunctive therapy for filtration surgery that does not use chemotherapy agents or radiation, but uses pharmacologically-active sensitizing compounds to produce a titratable, localized, transient, post operative avascular conjunctiva. A photosensitizing agent in a biological system is selectively activated by delivering the photosensitive agent to the biological system and laser activating only a spatially selected portion of the delivered photosensitive agent. The activated portion of the photosensitive agent reacts with the biological system to obtain a predetermined biological effect. As a result, an improved spatial disposition and effectuation of the biological effect by the photosensitive agent in the biological system is achieved.
    Type: Grant
    Filed: December 1, 1994
    Date of Patent: August 1, 2000
    Assignee: The Regents of the University of California
    Inventors: Richard A. Hill, Daniel R. Doiron, David H. Crean
  • Patent number: 6047095
    Abstract: A coplanar waveguide polymeric in-line fiber construct (CPW-PILF) formed on an optic half coupler substrate base or D-fiber wherein the surface is polished down through the cladding on the optical fiber so as to form an evanescent coupling region on the surface. Co-planar, spaced-apart electrodes are deposited on the surface with their gap aligned over the coupling region, and an electro-optic (EO) polymeric waveguide is deposited over the electrodes and between the electrode gap. Light transmitted thorough the optical fiber is evanescently coupled to said waveguide and modulated by a signal applied to the electrodes. Alternatively, the waveguide is deposited on the surface of the substrate and the electrodes are deposited over the waveguide.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: April 4, 2000
    Assignees: The Regents of the University of California, Optical Networks, Incorporated
    Inventors: Andre Knoesen, Diego Yankelevich, Scott A. Hamilton, Nicholas L. Abbott, Richard A. Hill, Gary Bjorklund
  • Patent number: 5968894
    Abstract: Pharmaceutical compositions comprising known verotoxins, particularly, verotoxin 1 and their pentameric subunit B, have been found to be useful in the treatment of mammalian neoplasia, particularly, brain cancer, ovarian cancer, breast cancer and skin cancer. Although verotoxin 1 has previously been shown to have anti-neoplastic activity in vitro, non-lethal doses of verotoxin 1 have been shown to be therapeutically anti-neoplastic in vivo. Use of a sensitizer, such as sodium butyrate, enhances the efficacy of verotoxins and their subunit B.
    Type: Grant
    Filed: November 28, 1995
    Date of Patent: October 19, 1999
    Inventors: Clifford A. Lingwood, Richard Hill, Hannah Farkas-Himsley, deceased, Ruth Geva, Leorah Kroyanker
  • Patent number: 5919161
    Abstract: Disclosed herein is a guidewire migration controller for use with catheter devices such as atherectomy catheters. The guidewire migration controller includes a housing, a gripper insertable in the housing and a locking member. The locking member holds the gripper within the housing. The gripper has an opening for receiving a guidewire. The gripper permits the guidewire to rotate and holds the guidewire to control guidewire migration.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: July 6, 1999
    Assignee: Devices for Vascular Intervention
    Inventors: E. Richard Hill, III, Glenn Davis, Brian Farley
  • Patent number: 5873815
    Abstract: A method and apparatus are provided for imaging a narrow body lumen, the method comprising maintaining separation between a distal end of an optical viewing scope and a lumen wall with a spacing structure which extends distally from the distal end of an access catheter. Optional spacing structures include distal cages and a guidewire which is fixed to and extends distally from the access catheter body. The invention is beneficial during either retrograde imaging of the fallopian tube, and also allows antigrade imaging and advancing the access catheter and scope under the direction of the image provided, as it prevents the tubal wall from coming into such close proximity to a falloposcope as to produce "white-out" on the imaging monitor.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: February 23, 1999
    Assignee: Conceptus, Inc.
    Inventors: John Kerin, Charles Milo, Julian N. Nikolchev, James Doty, Dai T. Ton, Richard Hill, Marc Schraner, Tom Kramer
  • Patent number: 5854864
    Abstract: A coplanar waveguide polymeric in-line fiber construct (CPW-PILF) formed on an optic half coupler substrate base or D-fiber wherein the surface is polished down through the cladding on the optical fiber so as to form an evanescent coupling region on the surface. Co-planar, spaced-apart electrodes are deposited on the surface with their gap aligned over the coupling region, and an electro-optic (EO) polymeric waveguide is deposited over the electrodes and between the electrode gap. Light transmitted thorough the optical fiber is evanescently coupled to said waveguide and modulated by a signal applied to the electrodes. Alternatively, the waveguide is deposited on the surface of the substrate and the electrodes are deposited over the waveguide.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: December 29, 1998
    Assignees: The Regents of the University of California, Optical Networks, Incorporated
    Inventors: Andre Knoesen, Diego Yankelevich, Scott A Hamilton, Nicholas L. Abbott, Richard A. Hill, Gary Bjorklund
  • Patent number: 5834688
    Abstract: A sensor cable formed of a center conductor surrounded by dielectric material and first and second layers. The first layer is formed of a gapped conductive material surrounding the dielectric material. The second layer has predetermined conductivity and at least covers the gaps in the conductive material of the first layer. The predetermined conductivity and thickness of the second layer is such that the skin depth in the second layer at an operating frequency of the cable is much greater than the thickness of the second layer, and inductive coupling into or out of the cable through gaps in the second layer is at least an order of magnitude greater than capacitive coupling into or out of the cable through gaps in the second layer.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: November 10, 1998
    Assignee: Senstar Stellar Corporation
    Inventors: Charles Richard Hill, Melvin Clive Maki